News | February 25, 2015

Seattle Cancer Care Alliance Proton Therapy Adds New Advanced Treatment Options

Pencil beam scanning, breath-hold device among new innovations

SCCA, proton therapy, radiation, RaySearch, RayStation, Active Breathing

February 25, 2015 — Physicians treating patients with complex tumors will have more advanced treatment options at Seattle Cancer Care Alliance Proton Therapy, a ProCure Center. The center will now offer pencil beam scanning (PBS) in its state-of-the-art gantry room. The combination of proton therapy with PBS technology enables physicians to better shape and direct radiation to the tumor, opening the doors to treat a wider variety of cancers.

“PBS is the most advanced way to deliver proton radiation and will allow us to sculpt protons for treating more complex tumors, such as in the head and neck, lung, abdomen, and pelvic areas,” said Smith ‘Jim’ Apisarnthanarax, M.D., a radiation oncologist at SCCA Proton Therapy.

SCCA Proton Therapy has also recently become the first proton center to use an advanced breath-hold device that aids patients in their ability to control breathing during radiation treatment. The Active Breathing Coordinator (ABC) device may be used when treating tumors in the chest or abdomen that move with breathing. It assists patients with systematically holding their breath before or after they’ve breathed out.

During this brief time, the ABC device makes the tumor a stationary target, allowing the treatment to be even more accurate, sparing surrounding tissue. The device’s ability to control breath both on inhale and exhale allows physicians to treat a range of tumors.

In addition, University of Washington Medicine physicians and SCCA Proton Therapy physicists are working together to upgrade the process for developing PBS patient treatment plans with RaySearch Laboratories‘ advanced treatment-planning and dose-tracking software platform, RayStation. RayStation combines the capabilities of traditional imaging such as computed tomography (CT), positron emission tomography (PET) and magnetic resonance imaging (MRI), with contouring and 4-D compatibility. Other features include multi-criteria optimization, dose tracking, treatment adaptation and near-real-time deformable image registration.

“Providing patients with the best treatment possible is our No. 1 priority and we believe investing in these advancements allows us to provide them with the highest levels of care,” said Ramesh Rengan, M.D., medical director at SCCA Proton Therapy. “These innovative technologies will make treatments more effective for patients, while shortening the overall treatment course for select cancers.”

For more information: www.sccaprotontherapy.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more